Resonance Health Azione

Resonance Health EV/OCF

Il EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo) di Resonance Health (RHT.AX) al 12 ago 2026 è 17,01. L'anno precedente, EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo) era 12,44 — una variazione del 36,77% (superiore).

EV/OCF

17,01

YoY

36,77%

Ultimo aggiornamento:

EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo) di Resonance Health ammonta a 2026 17,01 . EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo) di Resonance Health ammontava a 2025 12,44 . Diminuisce del 36,77% superiore rispetto all'anno precedente.
Access this data via the Eulerpool API

Resonance Health Analisi delle Azioni

Cosa fa Resonance Health? Resonance Health Ltd is an Australian company that operates in the medical technology industry. The company's business model is to offer groundbreaking solutions for the diagnosis and treatment of liver and iron diseases. As a pioneering company in the development of methods and technologies for quantifying liver and iron concentrations, Resonance Health continually sets new standards in the industry. The company was founded in 2000 by a team of biomedicine professionals from the University of Western Australia. Over the years, the company has gained a lot of experience and constantly evolved to keep up with the progress of medical technology. The goal is to provide patients with better treatment and improved quality of life. One division of the company is the development and manufacturing of diagnostic tools for quantifying liver and iron diseases such as hepatitis, fatty liver, or hemochromatosis. The quantification method used by Resonance Health is called FerriScan. This method is non-invasive and painless, using magnetic resonance imaging (MRI) to measure the concentration of iron in the tissue. This is particularly important as a change in iron content can indicate a progressing liver disease. In addition to the FerriScan diagnostic tool, Resonance Health also offers a software package for analyzing FerriScan results, which is used by physicians and clinicians to assess disease progression. Furthermore, the company also develops solutions in the field of hemochromatosis, a genetic disorder that can lead to increased iron levels in the body. Another division of Resonance Health is the provision of research and development services to further develop and improve FerriScan and other technologies. The company collaborates with other companies, scientific institutions, and universities to advance the current developments in liver and iron diagnostics. Resonance Health has a range of products that contribute to better diagnosis and treatment of liver and iron diseases. These include FerriScan, the FerriSmart software package for precise monitoring of iron and liver health, and Hepatica, a software supporting hospitals and clinics in the diagnosis of liver diseases. The company is an innovative leader in the industry, contributing to improving the quality of life for patients. The products and services of Resonance Health have helped doctors and clinicians to effectively treat and diagnose liver and iron diseases. Additionally, the company has established a strong scientific foundation and works closely with leading institutions to continuously develop innovative solutions. Resonance Health is a company with a rich history that continues to evolve to meet the demands of the medical technology industry. The company aims to continuously improve the diagnosis and treatment of liver and iron diseases and offer better solutions. Resonance Health è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su Resonance Health azioni

EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo) di Resonance Health è 17,01 nel 2026.

Il EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo) di Resonance Health è passato da 12,44 a 17,01, con una variazione del 36,77 %. Il valore è superiore rispetto all'anno precedente.

Su Eulerpool è possibile consultare lo sviluppo storico completo del Resonance Health di EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo) dal 2006, con valori annuali, grafici e analisi dettagliate.

EV/FCO confronta il valore d'impresa con il flusso di cassa operativo, misurando quanto gli investitori pagano per unità di contanti generati dalle operazioni.

Per valutare di EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo), è essenziale confrontarlo con i competitor nello stesso settore e industria. Su Eulerpool puoi trovare confronti diretti con l'industria per EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo).

Un 'buono' varia a seconda del settore e della fase di sviluppo dell'azienda. Su Eulerpool puoi confrontare Resonance Health di EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo) con i competitor del settore e la media industriale per valutare se è attraente.

Access this data via the Eulerpool API

Valutazione — Resonance Health

Tutte le Metriche Finanziarie — Resonance Health